US Moves to Turn Most Favored Nation Drug Pricing Policy Into Law

The U.S. government has begun talks with pharmaceutical companies to turn President Donald Trump’s Most Favored Nation drug pricing policy into permanent law, Chris Klomp, chief counselor at the Department of Health and Human Services, told reporters on March 19. “We’re also beginning to read in pharmaceutical ‌companies ⁠to help them understand the nature of the legislative text, to see if they can buy in, if there’s a version we might reach,” Klomp said. Trump launched the Most Favored Nation policy in May 2025 to eliminate the pricing gap between the United States and other wealthy nations. According to a July statement from the White House, Americans pay three times more for brand-name drugs than those in other developed nations, even after accounting for discounts manufacturers provide in the United States....